Veradigm is a U.S.-focused healthcare technology and analytics company that provides EHR, financial management, interoperability, de-identified data, and AI-enabled insights and platforms serving provider, payer, and life-science customers to improve health outcomes and reduce costs.

# Veradigm Inc.

## Overview
- Veradigm is a healthcare technology and analytics company serving three primary sectors: Provider, Payer, and Life Science.
- It delivers software, data, insights, and AI-enhanced solutions to improve health outcomes and reduce healthcare costs.
- Core capabilities include electronic health records (EHR), financial management, population health management, de-identified data, and patient communication tools.
- The company supports open interoperability and bi-directional data exchange among healthcare stakeholders, covering both clinical and financial workflows.

## Business model and platforms
- Offerings are built around integrated platforms that connect EHRs, practice management systems, and patient engagement tools.
- Solutions streamline workflows, enable interoperability with other software vendors, and support data exchange across care and payer communities.
- The company combines IT and point-of-care clinical and financial solutions with a focus on interoperability and data-driven decision making.

## Segments (effective January 1, 2023)
- Operations are organized into three segments:
  - Provider
  - Payer
  - Life Science
- Common revenue arrangements across segments include:
  - Support and maintenance
  - Software as a Service (SaaS)
  - Private cloud hosting
  - Network and processing solutions
  - Marketing impressions
  - Data
  - Software licenses
  - Professional services

## Provider segment
- Core offerings: cloud-based and hosted EHR platforms, practice management, revenue cycle services, and patient engagement tools.
- Objective: support healthcare provider practices of all sizes and specialties to improve clinical and financial outcomes.
- Focus: interconnected resources and services that help providers transition, analyze, and coordinate care.

## Data and insights (cross-segment)
- The company draws on an extensive provider footprint to provide scalable access to data and insights directly connected to point-of-care.
- These capabilities support customers’ transition toward value-based care.
- For life sciences, the data and insights support rapid generation of real-world evidence to accelerate therapy development and increase the value of existing therapies.
- The portfolio includes a patented risk adjustment methodology with dynamic intervention planning to help payers identify actionable interventions and reduce waste.

## Life Science segment
- Focus: de-identified data access, provider connectivity, and analytics at scale.
- Offers targeted biopharmaceutical messaging through EHRs via Veradigm’s platforms.

## Payer segment
- Focus: data and analytics to support risk adjustment and other payer objectives.
- Includes the patented risk adjustment methodology with dynamic intervention planning.

## Market and customer characteristics
- Veradigm maintains a large, diverse healthcare provider footprint.
- No single customer accounted for more than 10% of revenue in the years ended December 31, 2024, 2023, or 2022.
- No single customer accounted for more than 10% of accounts receivable as of December 31, 2024 or 2023.
- Substantially all revenue is generated from customers located in the United States.
- Corporate changes: on May 2, 2022, Veradigm sold the net assets of the HLPP business to Altera Digital Health Inc. On January 1, 2023, the company reorganized its reporting segments into Provider, Payer, and Life Science.

Veradigm Inc. is a healthcare technology and analytics company that focuses on transforming healthcare through data-driven solutions for providers, payers, and life sciences.

# Summary of Veradigm Inc.

**Company Overview:**
Veradigm Inc. (formerly known as Allscripts Healthcare Solutions, Inc.) is a healthcare technology and analytics company focusing on transforming healthcare through data, insights, and artificial intelligence (AI)-enhanced solutions. The company primarily addresses the needs of three pillars of healthcare: Providers, Payers, and Life Sciences.

### Business Segments:
1. **Provider Solutions:**
   - Offers cloud-based and hosted electronic health records (EHR), practice management systems, revenue cycle management, deidentified data, and patient engagement tools.
   - Serves over **450,000 healthcare providers** and covers **over 200 million patients**.
   - Revenue for the Provider segment in 2022: **$465.9 million** (79% of total revenue).
  
2. **Payer Solutions:**
   - Provides comprehensive solutions focusing on value-based care.
   - Revenue for the Payer and Life Sciences segment in 2022: **$122.1 million** (21% of total revenue).
   - Key solutions include clinical data exchange, payer analytics, and submissions to regulatory agencies.

3. **Life Sciences:**
   - Offers real-world data and research platforms and commercial media services that help improve patient care and provider engagement.
   - This segment's revenue is integrated within the Payer and Life Sciences total.

### Key Financial Metrics (for Fiscal Year Ended December 31, 2022):
- **Total Revenue:** $588.0 million (1.8% increase from 2021).
- **Gross Profit:** $308.4 million (52.5% gross margin).
- **Income (Loss) from Operations:** $(27.1) million.
- **Net Income (Loss):** $(86.5) million.

### Employee Overview:
- As of December 31, 2022, the company employed approximately **2,450 employees**.
- Employee distribution: **70% in the United States**, **28% in India**, and **2% in Bangladesh**.

### Recent Developments:
- Completed the sale of its Hospitals and Large Physician Practice (HLPP) business to Altera Digital Health Inc. in May 2022.
- Established a partnership with the U.S. Social Security Administration to facilitate electronic data requests through Veradigm's eChart Courier.
- Launched new platforms and solutions, including the Veradigm ePrescribe and Veradigm FollowMyHealth engagement software.
  
### Technology and Innovation:
- Committed to enhancing interoperability and AI-based solutions in healthcare.
- Holds multiple patents for innovative healthcare technology, including the Dynamic Intervention Planning process aimed at risk adjustment and intervention planning.

### Market Presence and Challenges:
- The company has faced challenges, including internal investigations leading to a restatement of financials and recent stock delisting from Nasdaq.
- It continues to focus on remediation efforts and compliance with regulatory requirements for financial disclosures and operations.

### Conclusion:
Veradigm Inc. stands at the intersection of healthcare innovation and analytics, leveraging technology to improve healthcare outcomes and efficiency for providers and payers alike. With a vast network of customers and a robust offering across various healthcare segments, it seeks to enhance patient care while navigating through recent operational challenges.

Veradigm Inc.

10-K / May 26, 2026

10-K / March 18, 2025

10-K / May 26, 2026

Veradigm Inc.

Overview

Business model and platforms

Segments (effective January 1, 2023)

Provider segment

Data and insights (cross-segment)

Life Science segment

Payer segment

Market and customer characteristics